Navigation Links
Clinical Data From Nymox BPH Drug To Be Presented at American,Urological Association Meeting

ement of BPH symptoms and includes data on 1) sensations of incomplete emptying of the bladder; 2) need to urinate frequently; 3) stopping and starting during urination; 4) urgent need to urinate; 5) weakness of urinary stream; 6) need to push or strain during urination; and 7) urination during sleep (nocturia). Published studies of currently approved drugs for BPH show AUA Symptom Score improvement in the 3.5 to 5 point range.

BPH afflicts approximately half of men over age 50 and close to 90% of men by age 80. The disorder causes difficulties with urination associated with aging, such as urination at night, urge to void frequently, hesitancy, weak stream, and other problems.

More information about Nymox is available at www.nymox.com, email: info@nymox.com, or 800-936-9669.

This press release contains certain "forward-looking statements" as defined in the United States Private Securities Litigation Reform Act of 1995 that involve a number of risks and uncertainties. There can be no assurance that such statements will prove to be accurate and the actual results and future events could differ materially from management's current expectations. The conduct of clinical trials and the development of drug products involve substantial risks and uncertainties and actual results may differ materially from expectations. Promising early results do not ensure that later stage or larger scale clinical trials will be successful or will proceed as expected. Such factors are detailed from time to time in Nymox's filings with the United States Securities and Exchange Commission and other regulatory authorities.

Contact

Nymox Pharmaceutical Corporation
Roy Wolvin, 1-800-93NYMOX
www.nymox.com


'"/>




Page: 1 2

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
4. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
Post Your Comments:
(Date:8/29/2014)... , Aug. 29, 2014   Vittamed Corporation , ... announced today that T. (Teo) Forcht Dagi ... the company,s Board of Directors. " Teo ... career in neurosurgery, medical innovation and venture capital," said ... extremely delighted to add his clinical, strategic, and entrepreneurial expertise ...
(Date:8/29/2014)... Aug. 29, 2014 /PRNewswire-iReach/ -- ChemImage will present a ... and New Zealand Forensic Science Society,s 22 nd ... Adelaide, Australia .  Forensic Scientists ... advancements that hyperspectral imaging can bring to examination ... , Director of Product Development at ChemImage, will ...
(Date:8/29/2014)... PASO ROBLES, Calif. , Aug. 29, 2014 /PRNewswire/ ... launch of its new website design . The ... an overhaul that showcases the company,s new services and ... By implementing a new streamlined design, viewers can ... deliver metrics for health care practices and create a ...
Breaking Medicine Technology:Vittamed Adds Prominent Neurosurgeon and Venture Capitalist T. Forcht Dagi to Board of Directors 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 3PMDS Announces New Website 2
... SAN DIEGO, Dec. 21, 2010 Arena Pharmaceuticals, Inc. (Nasdaq: ... President and Chief Executive Officer, will host a conference call ... Eastern Time (5:30 a.m. Pacific Time) to provide an update ... Food and Drug Administration (FDA) for the lorcaserin New Drug ...
... YORK, Dec. 21, 2010 Reportlinker.com announces that ... its catalogue: U.S. Preclinical ... http://www.reportlinker.com/p0350308/US-Preclinical-Animal-Imaging-Systems-Market.html This research ... Animal Imaging Systems Market since 2006. It examines ...
Cached Medicine Technology:Arena Pharmaceuticals to Host Conference Call and Webcast to Provide Update Following Lorcaserin End-of-Review Meeting With FDA 2Arena Pharmaceuticals to Host Conference Call and Webcast to Provide Update Following Lorcaserin End-of-Review Meeting With FDA 3
(Date:8/30/2014)... 30, 2014 Daily Gossip reveals in its ... Him Desire You program, who shows a unique formula to ... of this method says that the program goes beyond mere ... Him Desire You review indicates that the program was created ... and his great techniques to make a man feel emotionally ...
(Date:8/30/2014)... 30, 2014 The term nutraceuticals ... Pharameuticals. Nutraceuticals is a source of healthy-dietary supplements ... natural food sources. Nutraceutical ingredients have certain curative ... human body. Nutraceutical health products include factors such ... and more. Although nature is the most bountiful ...
(Date:8/30/2014)... Tenn. (PRWEB) August 30, 2014 ... around the country for the past several years, ... Tennessee Hyperbaric Center have announced a scholarship program ... This announcement follows a meeting held this summer ... In recent years, reporters have shed light on ...
(Date:8/30/2014)... York, New York (PRWEB) August 30, 2014 ... other incretin mimetic claims continue to move forward in ... statement issued by AstraZeneca PLC on July 31, 2014, ... been named in 409 product liability claims that allege ... Court documents indicate that many of these claims are ...
(Date:8/30/2014)... 30, 2014 In today’s world, a good ... get. Snoring and sleep apnea (a medical problem where the ... their bed partners of the rest they need to face ... population snores and 20 million people in the United States ... diagnosed and treated; and of those treated, many cannot tolerate ...
Breaking Medicine News(10 mins):Health News:Make Him Desire You Review Reveals Powerful Formula to Make a Man Emotionally Addicted 2Health News:A Granular Analysis of the Nutraceutical Ingredients Market by Transparency Market Research 2Health News:A Granular Analysis of the Nutraceutical Ingredients Market by Transparency Market Research 3Health News:A Granular Analysis of the Nutraceutical Ingredients Market by Transparency Market Research 4Health News:Tennessee Hyperbaric Center Offering HBOT Scholarships to Veterans 2Health News:Byetta Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Settlements in More than 80 Cases 2Health News:Byetta Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Settlements in More than 80 Cases 3Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3
... Teens who eat less salt lower their long-term risk for high ... finding stems from a computerized projection of what would happen if ... salt from their daily consumption of common processed foods. "Reducing ... that we eat could mean that teenagers live many more years ...
... , SATURDAY, Nov. 13 (HealthDay News) -- People who ... increased risk themselves for the potentially deadly heart rhythm ... data from 4,421 participants in the long-term Framingham Heart ... start of the study. Between 1968 and 2007, 440 ...
... say that physicians might be drawing conclusions too soon ... whose bodies were for a day initially chilled into ... as therapeutic hypothermia, is one of the few medical ... stoppages, with brain recovery usually assessed three days after ...
... HealthDay Reporter , FRIDAY, Nov. 12 (HealthDay News) -- ... have made significant discoveries in the past year that might ... disease in its tracks. That,s some good ... in 1991 as a joint project between the International Diabetes ...
... Northwestern Memorial Hospital recently implanted a patient with two ... available for study in humans. VADs are designed to ... or both (BiVAD) at once. This is the first ... the left and right ventricles anywhere in North Americaa ...
... (HealthDay News) -- A minor gene variation may be associated with ... study has found. In a recent experiment, Martin Reuter, of ... with this variation in a gene known as COMT gave away ... people with another variation of the gene. The COMT gene ...
Cached Medicine News:Health News:Study Urges Teens to Cut Down on Salt 2Health News:Study suggests physicians wait longer for brain recovery after hypothermia Rx in cardiac arrest 2Health News:Study suggests physicians wait longer for brain recovery after hypothermia Rx in cardiac arrest 3Health News:Diabetes Research Made Significant Strides in Past Year 2Health News:Diabetes Research Made Significant Strides in Past Year 3Health News:Small assist device used in emergency case as twin, heart booster pumps for first time in US 2
The MULTI-LINK PIXEL Coronary Stent System was designed to address the challenges of small vessel treatment in patients with abrupt or threatened abrupt closure (ATC)....
FemoStop system is a femoral compression system for hemostasis management. It provides a comfortable and efficient "hands off method of compressing the femoral artery and vein after diagnostic and i...
... VHD was the first ... bleeding after diagnostic and ... procedures. It is a ... approved for immediate sheath ...
... VHD was the first ... bleeding after diagnostic and ... procedures. It is a ... approved for immediate sheath ...
Medicine Products: